课题基金 / 基金详情

Proteome-wide analysis of sumoylation

Proteome-wide analysis of sumoylation
sumoylation 的全蛋白质组分析
批准号:
7030823
负责人:
Peter Kaiser
金额:
$17.39万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-01 至 2008-03-31

项目摘要

项目成果

Peter Kaiser的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Covalent modification of proteins by ubiquitin-like-proteins (Ubls) such as SUMO has been recognized as an important regulatory mechanism for most biological pathways, many of which are of great medical relevance. A comprehensive knowledge of Ubl-modification of proteins is therefore critical to understand how fundamental biological processes are regulated and to find new strategies for the treatment of a variety of diseases. To reach this goal, we propose to develop and apply tools to isolate and identify sumoylated proteins jn a proteomic scale. This will allow us to detect changes in sumoylation patterns in a variety of biological and medically relevant settings. The strategy we propose is to express SUMO fused to a tandem affinity-tag and generate a purified fraction of sumoylated proteins by a two-step affinity purification. The purified fractions will be analyzed by a combination of multidimensional liquid chromatography and tandem mass spectrometry [to generate sumoylation profiles. Such profiles will be valuable in identification of proteins that are modified with SUMO but more importantly, comparison of profiles generated from cells in different physiological or developmental states will help to identify important regulatory factors. The first aims will use yeast as a model system to detect quantitative changes in sumoylation patterns during |the different cell cycle stages and a cell cycle checkpoint arrest. Aim 2 attempts to adapt the approach from /east to mammalian cells and to quantitatively analyze changes in SUMO-1 modifications in response to a checkpoint-induced cell cycle arrest. This proposal is focused on identification of sumoylation targets, but we believe that the proposed strategy can applied to other modifications with ubiquitin-like proteins without any significant changes and will form the foundation for the generation of a variety of Ubl modification profiles.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of mutant p53 reactivation
  • 批准号:
    10719196
  • 项目类别:
  • 资助金额:
    $49.81万
  • 财政年份:
    2023
  • 负责人:
    Peter Kaiser
  • 依托单位:
Ubiquitin and Metabolite Signaling
  • 批准号:
    10552304
  • 项目类别:
  • 资助金额:
    $44.98万
  • 财政年份:
    2023
  • 负责人:
    Peter Kaiser
  • 依托单位:
Developing corrector small molecules for reactivation of mutant p53 in cancer
  • 批准号:
    10512976
  • 项目类别:
  • 资助金额:
    $21.0万
  • 财政年份:
    2022
  • 负责人:
    Peter Kaiser
  • 依托单位:
Developing corrector small molecules for reactivation of mutant p53 in cancer
  • 批准号:
    10675004
  • 项目类别:
  • 资助金额:
    $16.92万
  • 财政年份:
    2022
  • 负责人:
    Peter Kaiser
  • 依托单位:
国内基金
海外基金
SOD1介导星形胶质细胞活化调控hNSC移植细胞存活的机制研究
  • 批准号:
    82372136
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    付雪梅
  • 依托单位:
PCBP1和PCBP2调控cGAS的相变和酶活的机制研究
  • 批准号:
    32370928
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    孙钦秒
  • 依托单位:
利用密码子扩展技术对细胞焦亡中gasdermin家族蛋白行为进行特异性荧光标记与成像研究
  • 批准号:
    32200598
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    20.0万元
  • 批准年份:
    2022
  • 负责人:
    祝融峰
  • 依托单位:
自噬外泌体的鉴定及形成机制研究
  • 批准号:
    32100544
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2021
  • 负责人:
    高瑛
  • 依托单位: